Reimagining Cost-Effectiveness Analyses: A Role for Social Determinants of Health?

J Allergy Clin Immunol Pract. 2021 May;9(5):1948-1949. doi: 10.1016/j.jaip.2021.03.004.

Authors

Erika Raley¹, Akilah A Jefferson²

Affiliations

¹ Department of Internal Medicine, Dell Medical School at University of Texas at Austin, Austin, Texas.
² Department of Pediatrics, Division of Allergy and Immunology, University of Arkansas for Medical Sciences, Little Rock, Ark; Arkansas Children's Research Institute, Little Rock, Ark. Electronic address: aajefferson@uams.edu.

PMID: 33966871
DOI: 10.1016/j.jaip.2021.03.004

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aged
Asthma*
Cost-Benefit Analysis
Humans
Patients
Social Determinants of Health*
Tiotropium Bromide

Substances

Tiotropium Bromide